Stephane Bancel
Chief Executive Officer, Director · Moderna, Inc.
- 2026
- Aug 7, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephane Bancel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephen Hoge - $28.43M in MRNA purchases and sales in the last 12 months
- James M. Mock - $4.69M in MRNA purchases and sales in the last 12 months
- Shannon Thyme Klinger - $1.39M in MRNA purchases and sales in the last 12 months
- Noubar Afeyan - $434K in MRNA purchases and sales in the last 12 months
- Abbas Hussain - $265K in MRNA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephane Bancel?
Stephane Bancel is a corporate insider, tracked as Chief Executive Officer, Director of Moderna, Inc. (MRNA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Stephane Bancel submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Stephane Bancel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($28.72M) across all tracked filings.
